Erratum: Free drug samples in the United States: Characteristics of Pediatric Recipients and Safety Concerns (Pediatrics (2008) 122:4 (736-742) (DOI:10.1542/peds.2007-2928));Free drug samples in the united states: Characteristics of pediatric recipients and safety concerns

Pediatrics

Volumn 122, Issue 4, 2008, Pages 736-742

  Cutrona, Sarah L ^a,d   Woolhandler, Steffie ^a   Lasser, Karen E ^a   Bor, David H ^a   Himmelstein, David U ^a   Shrank, William H ^b   Leleiko, Neal S ^c  

^a CAMBRIDGE HEALTH ALLIANCE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HASBRO CHILDREN'S HOSPITAL   (United States)

^d CAMBRIDGE HOSPITAL   (United States)

Author keywords

Access to health care; Black warning box; Drug packaging; Drug safety; Free drug samples; Health insurance; Medically underserved; Uninsured

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHETAMINE; ATOMOXETINE; AZITHROMYCIN; BUDESONIDE; CEFDINIR; CETIRIZINE; FEXOFENADINE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; MOMETASONE FUROATE; MONTELUKAST; PIMECROLIMUS; SALBUTAMOL;

ADOLESCENT; ARTICLE; BIVARIATE ANALYSIS; CHILD; CHILD CARE; DRUG INDUSTRY; DRUG LABELING; DRUG MANUFACTURE; DRUG PACKAGING; DRUG SAFETY; FEMALE; HEALTH CARE ACCESS; HEALTH INSURANCE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; RECIPIENT; SAMPLING; SCHOOL CHILD; UNITED STATES; COMPARATIVE STUDY; ECONOMICS; HEALTH CARE DELIVERY; PATIENT; POVERTY; PRESCRIPTION; QUESTIONNAIRE; SOCIOECONOMICS; STATISTICS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG INDUSTRY; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFANT; INFANT, NEWBORN; INSURANCE, HEALTH; MALE; MEDICALLY UNINSURED; POVERTY; PRESCRIPTIONS, DRUG; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 54049154297     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-3307     Document Type: Erratum

References (24)

1. Cutrona SL, Woolhandler S, Lasser KE, Bor DH, McCormick D, Himmelstein DU. Characteristics of recipients of free prescription drug samples: a nationally representative analysis. Am J Public Health. 2008;98(2):284-289
2. Adair RF, Holmgren LR. Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med. 2005; 118(8):881-884
3. Stevens D, Sharma K, Kesten S. Insurance status and patient behavior with asthma medications. J Asthma. 2003;40(7): 789-793
4. Taira DA, Iwane KA, Chung RS. Prescription drugs: elderly enrollee reports of financial access, receipt of free samples, and discussion of generic equivalents related to type of coverage. Am J Manag Care. 2003;9(4):305-312
5. Backer EL, Lebsack JA, Van Tonder RJ, Crabtree BF. The value of pharmaceutical representative visits and medication samples in community-based family practices. J Fam Pract. 2000;49(9): 811-816
6. Dill JL, Generali JA. Medication sample labeling practices. Am J Health Syst Pharm. 2000;57(22):2087-2090
7. Peterson MC, Ebbert TL, Edwards MW, Willmore J. Disposition of pharmaceutical samples from a private medical clinic. JAm Pharm Assoc (2003). 2004;44(3):397-398
8. Westfall JM, McCabe J, Nicholas RA. Personal use of drug samples by physicians and office staff. JAMA. 1997;278(2): 141-143
9. Morelli D, Koenigsberg MR. Sample medication dispensing in a residency practice. J Fam Pract. 1992;34(1):42-48
10. Chew LD, O'Young TS, Hazlet TK, Bradley KA, Maynard C, Lessler DS. A physician survey of the effect of drug sample availability on physicians' behavior. J Gen Intern Med. 2000; 15(7):478-483
11. Boltri JM, Gordon ER, Vogel RL. Effect of antihypertensive samples on physician prescribing patterns. Fam Med. 2002; 34(10):729-731
12. Hall KB, Tett SE, Nissen LM. Perceptions of the influence of prescription medicine samples on prescribing by family physicians. Med Care. 2006;44(4):383-387
13. Shaughnessy AF, Bucci KK. Drug samples and family practice residents. Ann Pharmacother. 1997;31(11):1296-1300
14. Brewer D. The effect of drug sampling policies on residents' prescribing. Fam Med. 1998;30(7):482-486
15. Reeder M, Dougherty J, White LJ. Pharmaceutical representatives and emergency medicine residents: a national survey. Ann Emerg Med. 1993;22(10):1593-1596
16. Aspden P, Wolcott J, Bootman JL, Cronenwett LR, eds. Preventing Medication Errors: Quality Chasm Series. Washington, DC: National Academies Press; 2006. Available at: www.iom.edu/CMS/3809/22526/35939.aspx. Accessed August 1, 2007
17. Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D. A national survey of physician-industry relationships. N Engl J Med. 2007;356(17):1742-1750
18. Maguire P. Samples: cost-driver or safety net? ACP Internist. 2001. Available at: www.acponline.org/journals/news/jan01/drugsamples.htm. Accessed July 25, 2006
19. Johnson K. Drug samples to doctors. New York Times. February 9, 2006;A26
20. Cohen SB, DiGaetano R, Goksel H. Medical Expenditure Panel Survey: Methodology Report #5: Estimation Procedures in the 1996 MEPS Household Component. Rockville, MD: Agency for Healthcare Research and Quality; 1999. Available at: http://207.188.212.220/mepsweb/data-files/publications/mr5/mr5. shtml. Accessed September 12, 2006
21. Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH. Timing of new black box warnings and withdrawals for prescription medications. JAMA. 2002;287(17): 2215-2220
22. Westfall JM. Physicians, pharmaceutical representatives, and patients: who really benefits? J Fam Pract. 2000;49(9):817-819
23. Tong KL, Lien CY. Do pharmaceutical representatives misuse their drug samples? Can Fam Physician. 1995;41:1363-1366
24. Johnson D. Free (or Almost Free) Prescription Medications: Where and How to Get Them. San Francisco, CA: Robert D. Reed Publishers; 2002